Cargando…
Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers
Histone deacetylases 1 and 2 (HDAC1,2) belong to the class I HDAC family, which are targeted by the FDA-approved small molecule HDAC inhibitors currently used in cancer therapy. HDAC1,2 are recruited to DNA break sites during DNA repair and to chromatin around forks during DNA replication. Cancer ce...
Autor principal: | Bhaskara, Srividya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614045/ https://www.ncbi.nlm.nih.gov/pubmed/25942572 http://dx.doi.org/10.1080/15384101.2015.1042634 |
Ejemplares similares
-
Histone deacetylases 1 and 2 maintain S-phase chromatin and DNA replication fork progression
por: Bhaskara, Srividya, et al.
Publicado: (2013) -
Histone deacetylase 11 as a key regulator of metabolism and obesity
por: Bhaskara, Srividya
Publicado: (2018) -
Unbalanced Growth, the DNA Replication Cycle and Discovery of Repair Replication
por: Hanawalt, Philip C.
Publicado: (2023) -
The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair
por: Roos, Wynand Paul, et al.
Publicado: (2016) -
Targeting DNA Repair and Chromatin Crosstalk in Cancer Therapy
por: Johnson, Danielle P., et al.
Publicado: (2021)